Instructions for Contributors

Instructions for Authors for Neurotherapeutics® http://ees.elsevier.com/nurt/

Neurotherapeutics® is the official journal of the American Society for Experimental NeuroTherapeutics (ASENT).  Each issue of this publication provides critical invited reviews of an important topic relating to the treatment of neurological disorders. Neurotherapeutics® is published quarterly, in both print and full-text online versions. The journal includes critical literature reviews, examination of controversies, editorial commentaries and exploration of experimental, clinical, legislative, regulatory, societal and ethical issues that affect neurotherapeutics. Each issue of this journal has a special Guest Editor.  All review manuscripts will be solicited by the Guest Editor(s). Submission of a manuscript implies that the data have not been published previously and will not be submitted for publication elsewhere while the manuscript is under review.

Manuscript Preparation

Timeline: Because Neurotherapeutics® volumes are topic specific, it is very important that authors adhere to the deadlines as communicated by the Neurotherapeutics® editorial office or Guest Editor(s).  Articles cannot be rolled into a later issue.

 

Review process: With submission, authors should provide the name and contact information, including email address, of two reviewers who would be well suited to comment on the paper. Manuscripts are to be uploaded on the Elsevier Editorial System (EES) website, http://ees.elsevier.com/nurt/, where you will register, receive a log-in and password.General Format: All text should be double-spaced (including references, tables, and legends).  Margins should be 1 inch wide and all pages should be numbered.  The following sections must begin on separate pages:  Title page, Abstract/Key words, References, Acknowledgments, Tables, and Figure legends. PLEASE ADHERE TO THE FORMAT INSTRUCTIONS AS HEREIN SPECIFIED (in particular, ARTICLE LENGTH and in-text and end of article reference specifications).*A 12-point serif font, preferably Times New Roman, is required. Each article must fall in the range of 20 to 25 double-spaced pages in a word processing document including all figures, tables and references, unless otherwise instructed by the Guest Editor. If there are any subheadings of the article it should be clear by font size or style or numbering how they are formatted (major vs. minor vs. subminor, etc).*The Title Page must include the full title; a running title (not to exceed 40 characters); the author's full name (first name, middle initial, surname); the affiliations of all authors and their institutions, departments or organizations (use the following symbols in this order: *, †, ‡, §, ¶, ||, #, **, ††, ‡‡, §§, ¶¶, || ||, ##). Also on this page, the corresponding author’s address including telephone, fax numbers, and e-mail should be included at the bottom of this page.  *The Abstract must be 250 words or less and should be unstructured. References should not be included in the abstract. *Key Words: Please include at the end of the Abstract 5 or 6 Key Words or phrases to support indexing and information retrieval.*Acknowledgments must appear immediately after the text and before references. All grant support should be included in this section.Organization of Submitted Manuscripts:  Manuscript files should contain a title page, abstract or summary, key words, corresponding author information, section headings where appropriate, Acknowledgments, References, Table and Figure Legends, in addition to separate artwork files for figures (see instructions for artwork).  Reference Format: Neurotherapeutics® uses a reference format to mimic that of the journal Neurology, in order to make it easier for authors who wish to use EndNote or another reference software program.   

Journal article

Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934-939.  Published abstract van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJB, Eskens FALM, Delattre J-Y. Temozolomide chemotherapy in recurrent oligodendroglioma. Neurology 2000;54 (suppl 3):A12. Abstract.  Unpublished material Mark MH, Dickson DW, Schwarz KO, et al. Familial diffuse Lewy body disease. Presented at the 10th International Symposium on Parkinson's Disease; October 19, 1991; Tokyo.  Letter Neurology Assessment Panel. Assessment of neuropsychological testing. Neurology 1997;49:1183-1185. Letter.  Online book or website Garrow A, Weinhouse G. Anoxic brain injury: assessment and prognosis. In: UpToDate Cardiovascular Medicine [online]. Available at: www.UpToDateInc.com/card. Accessed February 22, 2006.  Online journal article Miyamoto O, Auer RN. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology [serial online] 2000;54:362-371. Available at: www.neurology.org. Accessed February 23, 2006.  Monograph in electronic format Chee M, Chiappa K. Waveguide: an EEG atlas on CD-ROM. Philadelphia: Lippincott Williams & Wilkins, 1998.  Computer file EMG analyzer software [computer program]. Version 1.0. Tustin, CA: B & L Engineering, 1998.  Online Correspondence Henderson VW, Drachman DA. Dementia and voter competence [electronic response to Swerdloff, Post-election anecdote]. Neurology 2002. http://www.neurology.org/cgi/eletters/58/7/995 (accessed 21 May 2002). Cross-citation: If possible, it is helpful to cite a few of the other articles in the dedicated volume. This will produce flow among the articles and cohesiveness to the volume. When another paper in the issue is cited the author should include the source in the numbered reference list and provide as much detail of the title and authors of the paper as is known, so that the Production Editor can complete the actual page range when the issue is compiled. To facilitate cross-citation, the Guest Editor(s) will provide a table of contents to authors a few weeks before the due date of the manuscript. Figure and Table Permissions: Authors need to have written permission in hand to reproduce any previously published figures and/or tables, and this information should be provided to the Guest Editor and Editorial Office. If no permission is required, a statement to that effect should be submitted. Abbreviations must be defined in the text with first use, but not defined again thereafter. Abbreviations should not be used only once unless it seems necessary for clarity. Abbreviations and their definitions must be consistent throughout the text. Figure Legends must be numbered with Arabic numerals in order of their mention in the text and should include a short title after the figure number. Where possible, symbols and patterns used to distinguish data must be defined in a key placed within the graphic rather than in the figure legend. Tables must be numbered with Arabic numerals in order of appearance in the text. Table legends are prepared as footnotes to the table and are included with the table.

 

Electronic Submission

Neurotherapeutics® requires electronic submission of manuscripts and illustrations. Files should be uploaded to the Elsevier Editorial System website, as per instructions available on the site (http://ees.elsevier.com/nurt/).Manuscripts should be prepared in Microsoft Word. Manuscript files should contain the Title page, Abstract, Key words, Corresponding Author information, Acknowledgments, References, Tables, Embedded Figures and Figure legends. In addition to embedded figures, the figures must be uploaded as high-resolution individual figure files (see below).

Figures should be prepared in electronic format as individual TIFF or EPS files. There is a question on the upload site regarding originality of the figures.  Resolution should be 300 dpi for images and 1200 dpi for line art. An image should submitted in the size at which the author would like it printed.  Combination artwork (an illustration containing both line art and photograph) should be created and saved as 600 to 1000 dpi.  For optimal results, scaling, rotation, and cropping should be done using an image editing program rather than a page layout program. All images must be easily readable and have good contrast.  Clarity and consistency should be uniform among the parts of a multipart figure, and among all of the figures within a manuscript. Each figure should be sized (column width and depth) to one of the following as desired for printing:

Each figure must be numbered according to its position in the text (Figure 1, Figure 2, and so on).  The electronic image files must be named so that the figure number and format can be easily identified.  For example, a Figure 1 in TIFF format should be named fig1.tif.  Multipart figures must be clearly identifiable by the file names: fig1A.tif, fig1B.fit, Fig1C.tif, etc.  The physical labels (A, B, C, etc.) will be added by the publisher.  Characters within the figure should be bold (not extra bold), with a maximum font size of 10 points (approx. 3.4 mm) and minimum of 9 points (approx. 3.2 mm).  A consistent font size should be used throughout each figure, and for all figures, to ensure readability and a professional appearance.  Titles or legends should not appear within the figure file, but should be provided in the manuscript legend.

Manuscripts published in Neurotherapeutics® become the sole property of, with all rights in copyright reserved to, the American Society for Experimental NeuroTherapeutics.  A copyright assignment form is signed by the corresponding author on behalf of all authors. Authors of articles written as part of their official duties as employees of the U.S. Government are exempt from this requirement for assignment transfer of copyright. Any previously copyrighted material reproduced in the manuscript, including modified figures and tables, must be accompanied by written permission from the copyright holder.